Back to search

National and Kapodistrian University of Athens

Διερεύνηση προγνωστικών παραγόντων και πλοειδικότητα στον καρκίνο του παγκρέατος

Abstract

dc:description

The majority of patients with pancreatic adenocarcinoma present with locally advanced or metastatic disease at diagnosis and only 15-20% of them have a resectable tumor. A large percentage does not respond well to the treatment as it is proved from the poor overall 5-year survival rates, which rarely exceed 5%. The aim of the present study was to identify the prognostic value of DNA ploidy in advanced pancreatic cancer in combination with other clinical and laboratorial prognostic factors. In this retrospective study we analyzed the data from the files of 226 patients. A series of 24 variables were analyzed statistically by regression analysis to identify prognostic factors that correlated with overall survival. Mean survival time was recorded at 38.41 weeks (95% c.i.: 33.17-43.65), median survival: 27.00 weeks (c.i.: 23.18-30.82). Among the 24 prognostic variables investigated initially at univariate analysis, 22 variables were identified as factors significantly associated with survival time except the age and sex. In multivariate analysis, using the Cox regression model, 9 variables demonstrated independence as prognostic factors. The patients had low values of performance status (PS?50), big weight loss (>10% of their initial weight), increased CEA levels (>10ng/ml), steatorhea, epo treatment, metastatic spread, stage 3 or 4 of the disease and finally no therapy or surgery only as treatment account for the poor prognosis of patients with advanced pancreatic cancer. On the contrary high values of performance status (PS?90), less weight loss (<5% of their initial weight), normal or decreased CEA levels (<5ng/ml), absence of steatorhea, absence of epo from the treatment regime, lack of metastatic spread, stage 1 or 2 of the disease, chemotherapy as sole treatment or combined with surgery are associated with better prognosis of these patients. Finally, high ploidy score is positively correlated with high risk of death while low ploidy score is positively correlated with low risk, this possibly being the most significant prognostic factor.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsigritis, Konstantinos
  • Τσιγκρίτης, Κωνσταντίνος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/18311

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsigritis, Konstantinos; Τσιγκρίτης, Κωνσταντίνος. Διερεύνηση προγνωστικών παραγόντων και πλοειδικότητα στον καρκίνο του παγκρέατος. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/18311